Mercury Laboratories Limited Share Price

Mercury Laboratories Limited Share Price

BSE: 538964
|
Pharmaceuticals
|
S Cap
₹ 817.00
+0.00 (0.00%)
1D
Last updated 22 Sep, 2026, 13:35 IST
--
0.00% up today
--
1D LOW
1D HIGH

Mercury Laboratories Limited Returns Calculator

Circuit
L
H
₹653.60
₹980.40
52-week
L
H
₹620.55
₹942.90

About Mercury Laboratories Limited

Mercury Laboratories Limited Share Price
ISIN
INE947G01011
Sector Market Cap
₹ 98.04 Cr

Mercury Laboratories Limited is an India-based pharmaceutical company. The Company operates through the Pharmaceuticals Products segment. It is engaged in the manufacturing and export of a range of pharmaceutical items. The products of the Company are in the segment of gynecology and pediatrics. Its products include antibiotic, antifungal, and antiviral formulations; anti-inflammatory formulations; antimalarial formulations; digestive formulations; hypoglycemic formulations; multivitamin formulations; central nervous system formulations; gynec formulations; CVS formulations; cough and cold formulations; and miscellaneous formulations, and innovative products. Its antibiotic, antifungal, and antiviral formulations include azithromycin tablets, azithromycin dispersible tablets, griseofulvin tablets, metronidazole tablets, and others. Its anti-inflammatory formulations include dexamethasone tablets, glucosamine sulphate tablets, dexamethasone sodium phosphate injection, and others.

Mercury Laboratories Limited Financial Highlights

  • Revenue: Mercury Laboratories Limited reported revenue of ₹77.90 crore in FY26 vs ₹76.17 crore in FY25. It showed an increase of 2.27% on a yearly basis.
  • Operating Profit: Mercury Laboratories Limited reported an operating profit of ₹6.64 crore in FY26 vs ₹4.66 crore in FY25. It showed an increase of 42.49% on a year-on-year basis.
  • Net Profit: Mercury Laboratories Limited reported a net profit of ₹4.83 crore in FY26 vs ₹3.14 crore in FY25. It showed an increase of 53.82% on a yearly basis.

Mercury Laboratories Limited Quarterly Result Highlights

  • Mercury Laboratories Limited reported revenue of ₹16.01 crore in Jun 2026, compared with ₹21.11 crore in Mar 2026, representing a decrease of 24.16% on a quarter-on-quarter (QoQ) basis.
  • Mercury Laboratories Limited reported an operating profit of ₹0.39 crore in Jun 2026, compared with ₹1.74 crore in Mar 2026, representing a decrease of 77.59% on a quarter-on-quarter (QoQ) basis.
  • Mercury Laboratories Limited reported a profit of ₹0.30 crore in Jun 2026, compared with ₹1.23 crore in Mar 2026, reflecting a decrease of 75.61% on a QoQ basis.
  • The earnings per share (EPS) of Mercury Laboratories Limited stood at ₹40.28 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
73.66%
FII
0.00%
Other DII
0.00%
Retail and other
26.34%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
98.04
P/E
23.54
P/B
1.69
ROE
8.32%
D/E
0.15
ROCE
10.75%
Div. Yield
0.43%
EPS(TTM)
40.28
Turnover
0.93
EV/EBITDA
10.77
Net Margin
6.36%
Op. Margin
13.96%
ROA
5.27%
Quick Ratio
3.24
Curr. Ratio
4.37
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Mercury Labs outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Mercury Labs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Mercury Laboratories Limited Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹75.94₹75.10₹75.56₹75.33
Other Income₹1.96₹1.07₹1.09₹1.72
Total Revenue₹77.89₹76.17₹76.65₹77.05
Total Expenses₹70.86₹71.51₹69.73₹69.61
Profit Before Tax₹6.64₹4.66₹6.92₹7.44
Tax₹1.80₹1.52₹1.27₹1.87
Profit After Tax₹4.83₹3.14₹5.65₹5.58
EPS - Basic₹40.28₹26.21₹47.12₹46.49
EPS - Diluted₹40.28₹26.21₹47.12₹46.49

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹6.64₹4.66₹6.92₹7.44
Income before WC changes₹10.60₹8.14₹10.12₹10.29
Change in Assets-₹2.01-₹4.91₹0.40-₹6.11
Change in Liabilities-₹3.09₹4.03-₹1.04-₹0.63
Change in WC-₹5.11-₹0.89-₹0.64-₹6.73
Cash flow from Operations₹4.24₹4.86₹8.23₹2.45
Cash flow from Investing-₹3.17-₹9.04-₹6.27-₹1.06
Cash flow from Financing₹2.91-₹1.85-₹1.04-₹1.01
Total Cash Flow₹3.99-₹6.03₹0.91₹0.38
Cash (Start of the year)₹2.19₹8.23₹7.32₹6.93
Cash (End of the year)₹6.18₹2.19₹8.23₹7.32

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹34.14₹35.01₹28.12₹24.71
Current Assets₹44.95₹39.22₹39.84₹39.46
Total Assets₹79.08₹74.24₹67.96₹64.16
Current Liabilities₹11.69₹15.08₹12.63₹14.18
Net Current Asset₹33.26₹24.15₹27.20₹25.28
Non-Current Liabilities₹9.32₹5.59₹4.49₹4.36
Equity Capital₹58.08₹53.57₹50.84₹45.63
Total Equity & Liabilities₹79.08₹74.24₹67.96₹64.16
* All values are in INR Crore
Qty
Bid
5
810
3
803
1
802
1
790
1
785
Ask
Qty
840
49
883
1
883.9
5
884
10
888
6
Bid Total: 11
Ask Total: 71
Buy orders: 13%
Sell orders: 87%
Bearish
2
Neutral
5
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
61.61
Neutral
ATR (14)
18.81
Neutral
STOCH(9,6)
49.62
Neutral
STOCH RSI (14)
100
Bearish
ADX(9)
37.72
Bearish
UO(9)
48.19
Neutral
ROC(12)
8.48
Bullish
WillR(14)
-50.38
Neutral
Period
Simple value
Exponential vaue
5D
794.91
799.78
10D
782.03
788.68
20D
774.75
782.79
50D
794.02
785.58
100D
785.26
786.63
Volume trend — traded volume by day
22 Sep0L
21 Sep0L
18 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Mercury Laboratories Limited Share Price
Mercury Laboratories Limited
Pharmaceuticals
Add Stock
Add Another

Mercury Laboratories Limited Share Price FAQs

Mercury Laboratories Limited share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837